NO307784B1 - Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav - Google Patents

Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav

Info

Publication number
NO307784B1
NO307784B1 NO950537A NO950537A NO307784B1 NO 307784 B1 NO307784 B1 NO 307784B1 NO 950537 A NO950537 A NO 950537A NO 950537 A NO950537 A NO 950537A NO 307784 B1 NO307784 B1 NO 307784B1
Authority
NO
Norway
Prior art keywords
benzodiazepin
polysubstituted
acylamino
intermediates
phenyl
Prior art date
Application number
NO950537A
Other languages
English (en)
Other versions
NO950537D0 (no
NO950537L (no
Inventor
Alain Badorc
Pierre Despeyroux
Daniele Gully
Paul De Cointet
Daniel Frehel
Jean-Pierre Maffrand
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9401642A external-priority patent/FR2716194B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO950537D0 publication Critical patent/NO950537D0/no
Publication of NO950537L publication Critical patent/NO950537L/no
Publication of NO307784B1 publication Critical patent/NO307784B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO950537A 1994-02-14 1995-02-13 Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav NO307784B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9401642A FR2716194B1 (fr) 1994-02-14 1994-02-14 Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR9408665A FR2716195B1 (fr) 1994-02-14 1994-07-12 Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Publications (3)

Publication Number Publication Date
NO950537D0 NO950537D0 (no) 1995-02-13
NO950537L NO950537L (no) 1995-08-15
NO307784B1 true NO307784B1 (no) 2000-05-29

Family

ID=26230950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950537A NO307784B1 (no) 1994-02-14 1995-02-13 Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav

Country Status (15)

Country Link
US (2) US5719143A (no)
EP (1) EP0667344A1 (no)
JP (1) JPH07300467A (no)
KR (1) KR950032145A (no)
CN (1) CN1053438C (no)
AU (1) AU692202B2 (no)
CA (1) CA2142411A1 (no)
FI (1) FI950625A (no)
FR (1) FR2716195B1 (no)
HU (1) HUT70050A (no)
IL (1) IL112589A (no)
NO (1) NO307784B1 (no)
NZ (1) NZ270478A (no)
PL (1) PL179904B1 (no)
TW (1) TW427982B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6528505B1 (en) 1998-06-22 2003-03-04 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6552013B1 (en) 1998-06-22 2003-04-22 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6774125B2 (en) 1998-06-22 2004-08-10 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
GB9920872D0 (en) 1999-09-04 1999-11-10 Glaxo Group Ltd Benzophenones as inhibitors of reverse transcriptase
GB0011092D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (III)
US20040167146A1 (en) * 2002-01-22 2004-08-26 Karen Jackson Method of treatment
US6713470B2 (en) * 2002-01-22 2004-03-30 Ml Laboratories Plc Method of treatment
US20040043990A1 (en) * 2002-04-09 2004-03-04 Karen Jackson Method of treatment
GB0221923D0 (en) * 2002-09-20 2002-10-30 Arrow Therapeutics Ltd Chemical compounds
EA012387B1 (ru) * 2002-09-20 2009-10-30 Эрроу Терапьютикс Лимитед Производные бензодиазепина, содержащие их продукт и фармацевтическая композиция и их применение
JP2007529261A (ja) * 2004-03-18 2007-10-25 コンティピ リミテッド 女性骨盤臓器脱出症治療装置
CN1950374A (zh) * 2004-05-25 2007-04-18 辉瑞产品公司 四氮杂苯并[e]甘菊环衍生物及其类似物
WO2010067233A1 (en) 2008-12-08 2010-06-17 Pfizer Inc. 1,2,4 triazolo [4, 3 -a] [1,5] benzodiazepin-5 (6h) -ones as agonists of the cholecystokinin-1 receptor (cck-ir)
CN102924448B (zh) * 2012-09-19 2015-02-25 渤海大学 生物碱cryptolepine类似物吲哚并喹啉酸化合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5023532B2 (no) * 1971-09-09 1975-08-08
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FI950625A0 (fi) 1995-02-13
PL179904B1 (pl) 2000-11-30
NO950537D0 (no) 1995-02-13
NO950537L (no) 1995-08-15
FR2716195A1 (fr) 1995-08-18
CA2142411A1 (en) 1995-08-15
FI950625A (fi) 1995-08-15
CN1126207A (zh) 1996-07-10
EP0667344A1 (fr) 1995-08-16
US5798353A (en) 1998-08-25
CN1053438C (zh) 2000-06-14
NZ270478A (en) 1996-12-20
TW427982B (en) 2001-04-01
KR950032145A (ko) 1995-12-20
IL112589A0 (en) 1995-05-26
HU9500434D0 (en) 1995-03-28
IL112589A (en) 2000-06-01
FR2716195B1 (fr) 1996-06-21
AU692202B2 (en) 1998-06-04
PL307255A1 (en) 1995-08-21
AU1166895A (en) 1995-08-24
HUT70050A (en) 1995-09-28
US5719143A (en) 1998-02-17
JPH07300467A (ja) 1995-11-14

Similar Documents

Publication Publication Date Title
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
NO307784B1 (no) Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav
HUP0000721A3 (en) Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them
NO981817L (no) Indolin-2-on-derivater, fremgangsmÕte for fremstilling av dem og farmas÷ytiske blandinger inneholdende dem
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
FI973279A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
EE04498B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon
FI963566A0 (fi) Uusia piperatsiinijohdoksia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä koostumuksia
NO305075B1 (no) Glycinamid-derivater, farmas°ytiske medikamenter som inneholder dem og mellomprodukter for fremstilling av dem
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
EE03929B1 (et) Sünteetilised polüsahhariidid, nende valmistamisemeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
HU9700955D0 (en) Substituted 2-naphtoylguanidine derivatives, their production, their use and pharmaceutical compositions containing them
EE03611B1 (et) Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO955320D0 (no) Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI960316A0 (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP0000203A3 (en) Naphthyl derivatives, pharmaceutical compositions containing them and intermediates
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
HU9700954D0 (en) Substituted 1-naphtoylguanidine derivatives, their production, their use and pharmaceutical compositions containing them
HUP9602774A3 (en) Benzoxazepine derivatives, pharmaceutical compositions containing them and intermediates
HUP0003104A3 (en) Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them